News
The move is expected to have knock-on effects on other sectors, such as transport and events, businesses told CNA, a day ...
An expert discusses the transformative impact of CAR T-cell therapy in relapsed/refractory large B-cell lymphoma, ...
Surrozen reported GAAP EPS of $2.55 for Q2 2025, exceeding expectations by $3.66 per share (GAAP) due to significant one-time and non-cash gains. Surrozen recorded $1.0 million in research service ...
4d
Vietnam Investment Review on MSNLuye Pharma Begins Phase 1 Trial for Triple Target AntidepressantLuye Pharma Group today announced that the first subject has been enrolled in a Phase 1 clinical trial in China for its LY03021, which was filed through China's Class 1 pathway for innovative drugs.
The official patch notes for Season 5 of Call of Duty: Black Ops 6 and Warzone have been released, detailing a number of ...
1don MSN
Americans are drowning in subscriptions for services like Netflix, Disney, and Verizon. So, they're saving money by joining family plans with friends.
Q2 2025 Earnings Call Transcript August 7, 2025 Operator: Good day, and thank you for standing by. Welcome to the Arcutis ...
14h
AZoBuild on MSNScientists Find Waste Foundry Sand Can Boost Concrete Strength, Lower Costs, and Support SustainabilityIntegrating waste foundry sand with SCMs like metakaolin and silica fume significantly boosts concrete strength and ...
You can technically use any barefoot shoe for strength training, but the VivoBarefoot Motus Strength was specially created ...
Corvus Pharmaceuticals reported a net loss per share of $(0.10) for Q2 2025, a smaller loss than the analyst estimate of $(0.13). Research and development expenses rose sharply to $7.9 million, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results